日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Minimally Invasive Glaucoma Surgery

微创青光眼手术

Voykov, Bogomil; Prokosch, Verena; Lübke, Jan

HOCPCA Exerts Neuroprotection on Retinal Ganglion Cells by Binding to CaMKIIα and Modulating Oxidative Stress and Neuroinflammation in Experimental Glaucoma.

HOCPCA 通过与 CaMKIIα 结合并调节实验性青光眼中的氧化应激和神经炎症,对视网膜神经节细胞发挥神经保护作用

Li Panpan, Shi Xin, Liu Hanhan, Feng Yuan, Wang Xiaosha, Herb Marc, Ji Haichao, Wagner Stefan, Vogt Johannes, Prokosch Verena

Tube erosions following glaucoma drainage device implantations

青光眼引流装置植入术后导管侵蚀

Prinz, Julia; Mercieca, Karl; Förster, Laura-Jill; Hilmers, Kira; Walter, Peter; Fuest, Matthias; Bachmann, Björn; Cursiefen, Claus; Prokosch, Verena

Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review

银杏叶提取物对青光眼各项指标的疗效:系统评价

Prinz, Julia; Prokosch, Verena; Wang, Xiaosha; Feng, Yuan; Walter, Peter; Fuest, Matthias; Migliorini, Filippo

Treatment outcomes of paul versus ahmed glaucoma implants

Paul 与 Ahmed 青光眼植入物的治疗效果比较

Prinz, Julia; Hilmers, Kira; Liegl, Constance; Walter, Peter; Mercieca, Karl; Prokosch, Verena

Factors influencing the outcomes of trabeculectomy, conventional canaloplasty, and mitomycin C augmented canaloplasty

影响小梁切除术、传统管成形术和丝裂霉素C增强管成形术疗效的因素

Prinz, Julia; Fuest, Matthias; Kuerten, David; Walter, Peter; Cursiefen, Claus; Prokosch, Verena

Anterior segment OCT for imaging PAUL(®) glaucoma implant patch grafts: a useful method for follow-up and risk management

前节OCT成像用于PAUL®青光眼植入补片移植:一种有用的随访和风险管理方法

Schipper, Pascal; Weber, Constance; Lu, Ke; Fan, Siqi; Prokosch, Verena; Holz, Frank G; Mercieca, Karl

Preoperative predictive thresholds for successful canaloplasty in glaucoma patients

青光眼患者术前小梁成形术成功预测阈值

Prinz, Julia; Epping, Carla-Maria; Kuerten, David; Fuest, Matthias; Cursiefen, Claus; Walter, Peter; Mercieca, Karl; Prokosch, Verena

Vision Restoration through transorbital electrical stimulation in Optic Neuropathy in patients with significant optic atrophy due to primary open-angle glaucoma-a randomised, controlled, double-blind, multicentre clinical trial: the VIRON study protocol

经眶电刺激治疗原发性开角型青光眼引起的显著视神经萎缩患者的视神经病变——一项随机、对照、双盲、多中心临床试验:VIRON 研究方案

Schittkowski, Michael; Pohlner, Johanna; Mercieca, Karl; Grohmann, Carsten; Kröger, Lena; Prokosch, Verena; Lorenz, Kathrin; Beck, Anna; Haueisen, Jens; Hunold, Alexander; Bernhard, Maria; Radbruch, Alexander; Dechent, Peter; Brockmann, Marc; Hoerauf, Hans; Bähr, Mathias; Wabbels, Bettina; Enders, Philip; Asendorf, Thomas; van Oterendorp, Christian; Antal, Andrea

Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide

了解青光眼:为何它仍然是全球主要的致盲原因之一

Qi, Tienan; Liu, Hanhan; Frühn, Layla; Löw, Katrin; Cursiefen, Claus; Prokosch, Verena